Arvind
Ravichandran

Mr. Ravichandran’s notable matters include representing:

• Occidental in its $57 billion acquisition of Anadarko and the $9.7 billion sale of OxyChem to Berkshire Hathaway;

• Shire in its $32 billion combination with Baxalta;

• Novartis in its $29.8 billion spin‑off of Alcon and its $11.4 billion spin‑off of Sandoz;
• Flowserve in its proposed $19 billion merger of equals with Chart Industries;
• Neuberger Berman in the $14.5 billion acquisition of Nord Anglia by a consortium comprising EQT, Neuberger Berman, CPP Investments and global institutional investors and in a significant investment in Mariner;
• BDT & MSD and its affiliates in connection with BDT’s combination with MSD, the formation of BDT Capital Partners Fund 4, which raised $14 billion of capital commitments, the take‑private acquisition of Weber, valuing Weber at $3.7 billion, and various private investments in excess of $3 billion;
• Aon in its $13 billion acquisition of NFP;
• Pinnacle Foods in its $10.9 billion acquisition by Conagra and its $975 million acquisition of Boulder Brands;
• MTN in its proposed $6.2 billion acquisition of IHS;
• A consortium led by Robert A. Ortenzio, Martin F. Jackson and WCAS in the pending $3.9 billion acquisition of Select Medical;
• Northrop Grumman in the $3.4 billion sale of its federal IT and mission support business to Veritas Capital;

• Roivant Sciences in its $3 billion Strategic Alliance with Sumitomo Dainippon Pharma;

• The special committee of the board of Eidos Therapeutics in the $2.83 billion merger with BridgeBio Pharma;

• IBM in multiple transactions, including its $2.6 billion acquisition of Truven Health Analytics, its acquisition of Resilient Systems and its acquisition of the product and technology businesses of The Weather Company;

• GreenSky in its $2.24 billion acquisition by Goldman Sachs;
• Star Bulk in its $2.1 billion combination with Eagle Bulk Shipping;

• Swvl in its $1.5 billion SPAC combination with Queen’s Gambit, including a $111.5 million PIPE investment and a $471.7 million equity financing facility;
• Alliance Laundry Systems in its $950.29 million IPO;

• GuideWell in its $900 million combination with Triple‑S Management;
• Outbrain in its $900 million acquisition of Teads;
• Talkspace in its pending $835 million acquisition by Universal Health Services;

• Lazard in its $575 million SPAC IPO;

• Eurazeo North America, as manager of funds affiliated with Eurazeo SE, in its capacity as controlling shareholder of WorldStrides and lender under the $368 million DIP facility in the pre‑packaged Chapter 11 proceedings of WorldStrides;

• Aramex in its $265 million acquisition of MyUS;

• Owl Rock in its investment in Amergin Asset Management and Fifth Season Investments’ $220 million acquisition of Fifth Season Financial and the life insurance investment assets of Chapford Capital II and Chapford Diversified Strategies Fund;
• Aras in its substantial growth investment from GI Partners;
• Barrick Gold in its joint venture with Newmont;
• Fitch Learning, a subsidiary of Hearst, in its acquisition of Moody’s Analytics Learning Solutions and the Canadian Securities Institute;
• Future Standard in its acquisition of the Digital Infrastructure platform of Post Road Group and its previous combination with Portfolio Advisors, creating a $75 billion alternative investment firm;
• Hayfin in the sale of Autovista to J.D. Power;
• Iris Financial, a Euronext Amsterdam‑listed SPAC sponsored by Ripplewood, in its combination with Younited;
• Martin Marietta in its exchange of certain assets with Quikrete;

• PG&E in various matters related to its bankruptcy and emergence, including its tri‑tranche offering, which represents the largest utility public equity offering in history;

• Proximo Spirits in its acquisition of the remaining stake in EBS, which owns Conor McGregor’s Proper No. Twelve Irish Whiskey brand;
• Tenax Aerospace in its pending merger with Air Industries Group;

• Unilever in the unification of its dual‑headed legal structure under a single parent company; and

• Xerox in its spin‑off of Conduent.

Mr. Ravichandran has been recognized as a leading tax practitioner by Chambers USA and The Legal 500 US. He was named a “Rising Star” by Law360 in 2023, recognizing him as one of four outstanding tax lawyers in the nation under the age of 40, and he has been recognized by Lawdragon as among the “500 Leading Dealmakers in America,” “500 Leading Global Tax Lawyers” and “500 X – The Next Generation.” Mr. Ravichandran is a member of the Executive Committee of the Tax Section of the New York State Bar Association and the Advisory Board of the Tax Law Center at NYU Law.

Mr. Ravichandran is a frequent speaker and author on significant tax law developments. He has spoken at events hosted by the American Tax Policy Institute, the Southern Federal Tax Institute and the Tax Section of the New York State Bar Association. Mr. Ravichandran authored “Private Equity Funds,” a Tax Management Portfolio, published by Bloomberg Tax. His writings have also been featured by the American Bankruptcy Law Journal, the Harvard Law School Bankruptcy Roundtable and Tax Notes, among others.

Mr. Ravichandran was born in State College, Pennsylvania. He received a B.A. from Columbia University in 2009 and a J.D. from Columbia Law School in 2012, where he was a James Kent Scholar and a Harlan Fiske Stone Scholar.

Mr. Ravichandran joined Cravath in 2015 and was elected a partner in 2021. Prior to joining Cravath, he worked as an attorney in the Internal Revenue Service Office of Chief Counsel. Mr. Ravichandran serves as a partner liaison to the Firm’s South Asian Affinity Group.